Pharmacogenomics
Determine optimal prescriptions by analyzing drug efficacy and side effect risk based on your patient’s genetic profile.
sequence once, query often®
TURNAROUND
New Patient6-9 days
SAMPLE
Saliva, Blood, Buccal
One comprehensive test provides clinical answers today and enables future queries as science evolves.
Clinical Utility
Identifies individuals who may benefit from:
- Medication selection tailored to their genetics
- Dose adjustments to reduce risk of medication side effects or to improve medication effectiveness
- More informed treatment decisions over time
TECH SPECS
Methodology
Whole gene sequencing using the Exome+® NGS (exome capture + deep intronic coverage in key regions).
Informatics
Special informatics applied to star alleles, including CYP2D6-CYP2D7 hybrid alleles, where up to five haplotypes can be detected.
Accuracy
> 99.9% across the full reportable range.
Helix pharmacogenomics panels comparison
View a full comparison of all Helix Pharmacogenomics tests here:
Helix Pharmacogenomics PanelsTest Catalog
Select a test below to view a detailed test description, technical specifications and complete gene list.
Pharmacogenomics (PGx) Level A Panel
A 16-gene pharmacogenomic panel based on CPIC Level A guidance for optimizing medication selection and dosing across cancer, cardiovascular, pain, and mental health conditions, powered by the Helix Exome+® platform.
16
genesComprehensive Pharmacogenomics (PGx) Panel
A comprehensive 27-gene pharmacogenomic panel for optimizing medication selection and dosing across cancer, cardiovascular disease, pain, mental health, and other conditions, powered by the Helix Exome+® platform.
27
genesPharmacogenomics (PGx) Clopidogrel CYP2C19 Test
A targeted pharmacogenomic test evaluating CYP2C19 metabolizer status to optimize clopidogrel prescription and dosing, powered by the Helix Exome+® platform.
1
genePharmacogenomics (PGx) Fluoropyrimidines DPYD Test
A targeted pharmacogenomic test evaluating the DPYD gene to predict fluoropyrimidine treatment efficacy and side effect risk, powered by the Helix Exome+® platform.
1
gene